Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

키워드

참고문헌 (36)

1. Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", Hepatology, 40, pp.1387~1395 (2004)
2. Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference", Hepatology, 37, pp.1202~1219 (2003)
3. Salamone F, "Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome", J Hepatol, 53, pp.1146~1147 (2010)
4. Choi SY, "The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans", AMERICAN JOURNAL OF GASTROENTEROLOGY, 104, pp.1953~1960 (2009), NATURE PUBLISHING GROUP
5. Speliotes EK, "Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study", Hepatology, 51, pp.1979~1987 (2010)
6. Chen SH, "Relationship between nonalcoholic fatty liver disease and metabolic syndrome", J Dig Dis, 12, pp.125~130 (2011)
7. Oliveira CP, "Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet", J Cell Mol Med, 6, pp.399~406 (2002)
8. Sumida Y, "Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease", J Hepatol, 38, pp.32~38 (2003)
9. Seki S, "Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases", Hepatol Res, 33, pp.132~134 (2005)
10. Morita M, "Fatty liver induced by free radicals and lipid peroxidation", Free Radic Res, 46, pp.758~765 (2012)
11. Terao K, "Damage to biological tissues induced by radical initiator 2,2’-azobis(2-amidinopropane) dihydrochloride and its inhibition by chain-breaking antioxidants", J Free Radic Biol Med, 2, pp.193~201 (1986)
12. Shimasaki H, "Free radical-induced liver injury. II. Effects of intraperitoneally administered 2,2’-azobis(2-amidinopropane) dihydrochloride on the fatty acid profiles of hepatic triacylglycerol and phospholipids", Free Radic Res Commun, 14, pp.247~252 (1991)
13. Sanyal AJ, "A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis", Clin Gastroenterol Hepatol, 2, pp.1107~1115 (2004)
14. Stocker R, "Bilirubin is an antioxidant of possible physiological importance", Science, 235, pp.1043~1046 (1987)
15. Baranano DE, "Biliverdin reductase: a major physiologic cytoprotectant", Proc Natl Acad Sci U S A, 99, pp.16093~16098 (2002)
16. Stocker R, "Antioxidant activities of bile pigments", Antioxid Redox Signal, 6, pp.841~849 (2004)
17. Lin LY, "Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents", Atherosclerosis, 203, pp.563~568 (2009)
18. Cheriyath P, "High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006", J Clin Med Res, 2, pp.201~206 (2010)
19. Lin JP, "Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study", Circulation, 114, pp.1476~1481 (2006)
20. Perlstein TS, "Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004", Am J Med, 121, pp.781~788.e1 (2008)
21. Chang Y, "A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean Workers", PLOS ONE, 7(5), pp.e37241~ (2012), Public Library of Science
22. Hjelkrem M, "Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH)", Aliment Pharmacol Ther, 35, pp.1416~1423 (2012)
23. Kumar R, "Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response", Clin Biochem, 45, pp.272~274 (2012)
24. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
25. The Asia-Pacific perspective: redefining obesity and its treatment, "World Health Organization", Health Communications, 15~21 (2000)
26. Vítek L, "Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels", Atherosclerosis, 160, pp.449~456 (2002)
27. Schwertner HA, "Association of low serum concentration of bilirubin with increased risk of coronary artery disease", Clin Chem, 40, pp.18~23 (1994)
28. Hopkins PN, "Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease", Arterioscler Thromb Vasc Biol, 16, pp.250~255 (1996)
29. Madhavan M, "Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults", Atherosclerosis, 131, pp.107~113 (1997)
30. Vítek L, "The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases", Front Pharmacol, 3, pp.55~ (2012)
31. Pagano G, "Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association", Hepatology, 35, pp.367~372 (2002)
32. Ruhl CE, "Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States", Gastroenterology, 124, pp.71~79 (2003)
33. Sanyal AJ, "Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities", Gastroenterology, 120, pp.1183~1192 (2001)
34. Wu ML, "A central role of heme oxygenase-1 in cardiovascular protection", Antioxid Redox Signal, 15, pp.1835~1846 (2011)
35. Yu J, "Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice", Gastroenterology, 138, pp.694~704 (2010)
36. Muraca M, "Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver", Gastroenterology, 87, pp.308~313 (1984)

관련 논문AI추천